Positive control genes, such as RPL13a, beta-actin, beta 2 microglobulin or GAPDH, should be included as a positive control to eliminate operational error and reagent- or equipment-related issues. If signal is observed with the positive control probe set, but not the gene of interest, the following should be considered:
- Ensure that your instrument settings have been optimized for detection of the PrimeFlow probe sets and that you are using the appropriate compensation controls. Compensation for PrimeFlow target probe sets should be conducted using the PrimeFlow Compensation Kit. Fluorochrome-conjugated antibodies should not be used for setting compensation.
- Verify expression of the target gene with other methods of RNA expression analysis such as QuantiGene 2.0 bDNA assay, qPCR, microarray, or RNA sequencing. Ensure that the same sample type, treatment conditions, and time courses are used across the various assays. If gene expression is proven by other assays, verify that the same RNA region is targeted by the PrimeFlow Target Probes. We can design probe sets to cover the same RNA region that has been detected by other assays. Please contact Technical Support for additional assistance (techsupport@thermofisher.com).
- Protein expression may not correlate with RNA expression due to differences in expression kinetics and stability of the transcript. For example, changes in the levels of RNA may occur before expression of protein, after which the levels of RNA may drop while the expression of protein remains high. If using an induction model, a time course should be performed to determine the optimal time point to detect expression of the RNA of interest.
- Genes may not be detectable with the PrimeFlow Assay due to low expression levels or inefficiency of unmasking of the mRNA transcript.
Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.
Answer Id: E14657
Yes
No
Thank you for your response